+(91) 79 4891 1722



Eptifibatide is an antiplateletdrug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclicheptapeptide derived from a protein found in the venom of the southeasternpygmy rattlesnake.

Ralington pharma LLP (India), a globalmanufacturer and supplier for Eptifibatide, 188627-80-7 for R&D, Pilot orCommercials  Quantities withPharmacopeial Grade USP/ EP/ BP/ IP/ JP/In-House.

Eptifibatide, 188627-80-7 availablewith USDMF,EDMF, DMF, USFDA, EUGMP, GMP,ISO CERTIFIED,WHO-GMP and DMF as per the requirement. Product supply inStandard Packaging & labeling as per FDA along with supportivedocumentation. We can also offer Intermediates of  Eptifibatide, 188627-80-7.

ProductType : API
Molecular Formula : C35H49N11O9S2
CASNo : 188627-80-7
Grades : USP,BP,EP,DMF,GMP,Technical Package,USDMF,EDMF
Molecular Weight : 831.96
Synonym : N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide,,,

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).